Clinical trial
A Prospective Study Evaluating Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
NCT05108519 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study Evaluating Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 8, 2019
- Completion date
- February 2, 2027
- Enrollment
- 170 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm